Characteristics of menstruation and pregnancy and the risk of lung cancer in women

International Journal of Cancer

Volumn 125, Issue 10, 2009, Pages 2428-2433

  Koushik, Anita ^a,b   Parent, Marie Élise ^b,c   Siemiatycki, Jack ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Case control study; Hormones; Lung cancer; Menopause; Reproductive factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CANCER RISK; CHILD; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUATION; OVARIECTOMY; PREGNANCY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; CANADA; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MENSTRUATION; MIDDLE AGED; OVARIECTOMY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RISK FACTORS; SMALL CELL LUNG CARCINOMA;

EID: 70349871221     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24560     Document Type: Article

References (39)

1. IARC. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2004.
2. Parkin DM, Sasco AJ. Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer 1993;9:1-16.
3. Abraham J, Gulley JL, Allegra CJ. Bethesda handbook of clinical oncology. Philadelphia: Lippincott Williams & Wilkins, 2005.
4. Subramanian J, Govindan R. Lung cancer in never smokers:DOI 10.1002/ijc.24560 a review. J Clin Oncol 2007;25:561-570
5. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet 2001;2:506-513
6. Pauk N, Kubik A, Zatloukal P, Krepela E. Lung cancer in women. Lung Cancer 2005;48:1-9.
7. Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin LI, Zhang R, Fraumeni JF. Lung cancer among chinese women. Int J Cancer 1987;40:604-609
8. Wu AH, Henderson BE, Pike MC, Mimi CY. Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst 1985;74:747-751 (Pubitemid 15118227)
9. Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE. Personal and family history of lung disease as risk factors for adenocarcinoma. Cancer Res 1988;48:7279-7284 (Pubitemid 19014017)
10. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44:833-839 (Pubitemid 20007980)
11. Wu-Williams AH, Dai XD, Blot W, Xu ZY, Sun XW, Xiao HP, Stone BJ, Yu SF, Feng YP, Ershow AG, Sun J, Fraumeni JF, et al. Lung cancer among women in north-east China. Br J Cancer 1990;62:982-987
12. Taioli E, Wynder EL. Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-870
13. Liao ML, Wang JH, Wang HM, Ou AQ, Wang XJ, You WQ. A study of the association between squamous cell carcinoma and adenocarcinoma in the lung, and history of menstruation in Shanghai women, China. Lung Cancer 1996;14:S215-21.
14. Blackman JA, Coogan PF, Rosenberg L, Strom BL, Zauber AG, Palmer JR, Langenberg P, Shapiro S. Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf 2002;11:561-567 (Pubitemid 35345406)
15. Seow A, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Chia KS, Yu MC, Lee HP. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer 2002;97:365-371 (Pubitemid 34049029)
16. Olsson H, Bladstr€om A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003;102:565-570
17. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE. Hormonal factors and risk of lung cancer among women? Int J Epidemiol 2003;32:263-271
18. Brenner AV, Wang Z, Kleinerman RA, Lei S, Metayer C, Wang W, Lubin JH. Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994-1998. J Epidemiol 2003;13:22-28
19. Schabath MW, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung caner risk: a case-control analysis. Clin Cancer Res 2004;10:113-123 (Pubitemid 38114169)
20. Liu Y, Inoue M, Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 2005;117:662-666 (Pubitemid 41504556)
21. Elliott AM, Hannaford PC. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 2006;73:331-335
22. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 2007;120:2214-2220 (Pubitemid 46555861)
23. Weiss JM, Lacey JV, Jr, Shu XO, Ji BT, Hou L, Yang G, Li H, Rothman N, Blair A, Gao YT, Chow WH, Zheng W. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008;168:1319-1325
24. Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 2007;25:5785-5792
25. Ramnath N, Menezes RJ, Loewen G, Dua P, Eid F, Alkhaddo J, Paganelli G, Natarajan N, Reid ME. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Oncology 2007;73:305-310 (Pubitemid 351862020)
26. Chen KY, Hsiao CF, Chang GC, Tsai YH, Su WC, Perng RP, Huang MS, Hsiung CA, Chen CJ, Yang PC. Hormone replacement therapy and lung cancer risk in Chinese. Cancer 2007;110:1768-1775 (Pubitemid 47557301)
27. Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ, Calle EE. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2008;17:655-660
28. Ramanakumar AV, Parent ME, Siemiatycki J. Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada. Am J Epidemiol 2007;165:634-642 (Pubitemid 46348381)
29. IARC. Histological groups for comparative studies. Technical report no. 31. Lyon, France: IARC, 1998.
30. Langenberg P, Kjerulff KH, Stolley PD. Hormone replacement and menopausal symptoms following hysterectomy. Am J Epidemiol 1997;146:870-880 (Pubitemid 27498104)
31. Leffondre K, Abrahamowicz M, Xiao Y, Siemiatycki J. Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat Med 2006;25:4132-4146 (Pubitemid 46023761)
32. Benedetti A, Parent ME, Siemiatycki J. Consumption of alcoholic beverages and risk of lung cancer: results from two case-control studies in Montreal, Canada. Cancer Causes Control 2006;17:469-480
33. Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling smoking history: a comparison of different approaches. Am J Epidemiol 2002;156:813-823 (Pubitemid 35215762)
34. Gelfand MM. Role of androgens in surgical menopause. Am J Obstet Gynecol 1999;180:S325-7.
35. Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med 2005;118 Suppl 12B:131-135
36. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999;180:S312-6.
37. Ettinger B, Friedman GD, Bush T, Quesenberry CP. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12. (Pubitemid 26015941)
38. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002;67:979-983 (Pubitemid 35175465)
39. Westhoff C, Gentile G, Lee J, Zacur H, Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol 1996;144:381-388 (Pubitemid 26262201)